Loading...
Sorafenib for the treatment of advanced hepatocellular cancer - a UK audit.
King, J Palmer, D Johnson, P Ross, P Hubner, Richard A Sumpter, K Darby, S Braconi, C Iwuji, C Swinson, D
King, J
Palmer, D
Johnson, P
Ross, P
Hubner, Richard A
Sumpter, K
Darby, S
Braconi, C
Iwuji, C
Swinson, D
Citations
Altmetric:
Abstract
Sorafenib is the current standard treatment for advanced hepatocellular carcinoma. We carried out a national audit of UK patients treated with sorafenib as standard-of-care and those treated with systemic therapy in first-line trials.
Description
Date
2016-12-10
Publisher
Collections
Keywords
Type
Article
Citation
Sorafenib for the treatment of advanced hepatocellular cancer - a UK audit. 2016, Clin Oncol